162 related articles for article (PubMed ID: 35770457)
1. Paternal use of medications for inflammatory bowel disease and the risk of hospital-diagnosed infections in the offspring: a nationwide cohort study.
Friedman S; Garvik OS; Nielsen J; Nørgård BM
Aliment Pharmacol Ther; 2022 Sep; 56(5):823-830. PubMed ID: 35770457
[TBL] [Abstract][Full Text] [Related]
2. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.
Larsen MD; Friedman S; Magnussen B; Nørgård BM
Am J Gastroenterol; 2016 Nov; 111(11):1608-1613. PubMed ID: 27619836
[TBL] [Abstract][Full Text] [Related]
3. Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor.
Meyer A; Taine M; Drouin J; Weill A; Carbonnel F; Dray-Spira R
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1269-1281.e9. PubMed ID: 34298191
[TBL] [Abstract][Full Text] [Related]
4. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study.
Thomsen SB; Ungaro RC; Allin KH; Elmahdi R; Poulsen G; Andersson M; Colombel JF; Jess T
Aliment Pharmacol Ther; 2022 May; 55(9):1128-1138. PubMed ID: 35080036
[TBL] [Abstract][Full Text] [Related]
5. Adverse Birth and Child Outcomes in Children Fathered by Men Treated with Antidiabetics Prior to Conception: A Nationwide Cohort Study.
Nørgård BM; Fedder J; Jølving LR; Damkier P; Nielsen J
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362820
[TBL] [Abstract][Full Text] [Related]
6. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
Nørgård BM; Magnussen B; Larsen MD; Friedman S
Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
[TBL] [Abstract][Full Text] [Related]
7. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
8. Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.
Biron A; Beaugerie L; Chazouillères O; Kirchgesner J
Aliment Pharmacol Ther; 2022 Sep; 56(5):857-868. PubMed ID: 35789494
[TBL] [Abstract][Full Text] [Related]
9. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study.
Jølving LR; Nielsen J; Andersen ML; Friedman S; Nørgård BM
BMC Med; 2023 Apr; 21(1):140. PubMed ID: 37046314
[TBL] [Abstract][Full Text] [Related]
10. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
Kirchgesner J; Nyboe Andersen N; Carrat F; Jess T; Beaugerie L;
Gut; 2020 May; 69(5):852-858. PubMed ID: 31446428
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of pneumonia among patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
[TBL] [Abstract][Full Text] [Related]
12. In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark.
Nørgård BM; Nielsen J; Friedman S
Aliment Pharmacol Ther; 2020 Sep; 52(5):829-842. PubMed ID: 32677731
[TBL] [Abstract][Full Text] [Related]
13. Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases.
Dheyriat L; Ward D; Beaugerie L; Jess T; Kirchgesner J
Clin Gastroenterol Hepatol; 2023 Jan; 21(1):164-172.e11. PubMed ID: 35842123
[TBL] [Abstract][Full Text] [Related]
14. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
[TBL] [Abstract][Full Text] [Related]
15. Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries-A nationwide cohort study.
Nørgård BM; Zegers FD; Knudsen T; Kjeldsen J; Lund K; Brodersen JB; Nielsen J
Aliment Pharmacol Ther; 2023 Jul; 58(1):48-59. PubMed ID: 37078376
[TBL] [Abstract][Full Text] [Related]
16. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
Bröms G; Granath F; Stephansson O; Kieler H
Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
[TBL] [Abstract][Full Text] [Related]
18. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
Meserve J; Luo J; Zhu W; Veeravalli N; Bandoli G; Chambers CD; Singh AG; Boland BS; Sandborn WJ; Mahadevan U; Singh S
Gastroenterology; 2021 Jul; 161(1):107-115.e3. PubMed ID: 33744307
[TBL] [Abstract][Full Text] [Related]
19. Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.
Meyer A; Neumann A; Drouin J; Weill A; Carbonnel F; Dray-Spira R
Ann Intern Med; 2022 Oct; 175(10):1374-1382. PubMed ID: 36162111
[TBL] [Abstract][Full Text] [Related]
20. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
Gregory MH; Ciorba MA; Wiitala WL; Stidham RW; Higgins P; Morley SC; Hou JK; Feagins LA; Govani SM; Cohen-Mekelburg SA; Waljee AK
Inflamm Bowel Dis; 2020 May; 26(6):919-925. PubMed ID: 31504531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
